glycyrrhizic acid has been researched along with Hepatopulmonary Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, D; Chen, C; Li, T; Li, X; Lin, Y; Liu, J; Wang, Q; Yang, S; Yin, H; Zhao, X | 1 |
1 other study(ies) available for glycyrrhizic acid and Hepatopulmonary Syndrome
| Article | Year |
|---|---|
Diammonium glycyrrhizinate alleviates hepatopulmonary syndrome via restoring superoxide dismutase 3 activity in rats.
Topics: Animals; Gene Expression Regulation, Enzymologic; Glycyrrhizic Acid; Hepatopulmonary Syndrome; Liver; Male; Nitric Oxide; Rats; Rats, Wistar; Superoxide Dismutase | 2017 |